PATENT CLAIM ANALYSIS

Application Number: 15746206
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "264100"]

Abstract:
Provided herein are new therapeutic regimens for treatment of cancer with a combination of a JAK inhibitor and an inhibitor targeting the MAPK pathway, combinations and methods of use thereof. In some embodiments, described herein are methods for treating cancer in an individual in need thereof, comprising administration of a JAK inhibitor and an inhibitor targeting the MAPK pathway to the individual. In some embodiments, the JAK inhibitor is a JAKI inhibitor.

Claim (Index 34):
The method of any one of  claims 28  to  31 , wherein the inhibitor targeting the MAPK pathway is an ERK1/2 inhibitor.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 86.0
- Lexical Diversity: 1.975
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15580991', '15002457', '14147689', '15160729', '15023229']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8218425718817163
- 35 USC 102 Novelty (BERT): 0.546428398976466
- Combined Prediction Score: 0.7943011545911913
- Mean Citation Score: 379.438454
- Max Citation Score: 431.50165
- Similarity Product: 255.5606027332425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test